Jerusalem, Israel, December 29, 2009 - Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) invites investors and the general public to listen to a webcast of an analyst meeting on Thursday, January 7, 2010, at 3:00 p.m. ET. The purpose of the meeting will be to provide an update on Teva's long term strategy.
What: Teva's Strategy Update
Who: Teva's Management
When: Thursday, January 7, 2010, 3:00 p.m. to 6:00 p.m. ET.
How: Live over the Internet - log on to the Web at the address above and register for the event (approx. 10 minutes before). An archive of the webcast will be available on Teva's website.
Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 20 pharmaceutical companies in the world and is the leading generic pharmaceutical company. The company develops, manufactures and markets generic and innovative pharmaceuticals and active pharmaceutical ingredients. Over 80 percent of Teva's sales are in North America and Western Europe.